Source: International Congress 2016 – Lung function and imaging: new findings and new approaches
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Roberta Sudy (Szeged, Hungary), Roberta Sudy, Adam L. Balogh, Gergely H. Fodor, Barna Babik, Ferenc Petak, Orsolya Ivankovitsne Kiss. Levosimendan reduces cholinergic bronchoconstriction: The role of KATP channels. Eur Respir J 2016; 48: Suppl. 60, 2235

Member's Comments

No comment yet.

Related content which might interest you: TRPV4 and activation of airway sensory nerves: The role of ATP Source: International Congress 2015 – Novel targets and strategies for the treatment of cough, asthma, rhinosinusitis and COPD Year: 2015 Dobutamine decreases an elevated airway tone similar to dopamine in rats Source: International Congress 2016 – Respiratory muscles and airways function: from physiology to clinical implications Year: 2016 Effects of dopamine on the elevated airway tone by histamine and methacholine in rabbits Source: International Congress 2014 – Clinical physiology and respiratory muscles Year: 2014 Activation of TRPV4 causes bronchoconstriction: A possible role in respiratory disease? Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD Year: 2013 CRAC channel inhibition by RP3128 ameliorates airway hyper-reactivity in antigen sensitized mice and guinea pigs Source: International Congress 2014 – Novel targets and drugs for asthma and COPD Year: 2014 Alpha-7 nicotinic receptor stimulation reduces airway inflammation in a murine model of asthma Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action Year: 2016 The TRPV4 ion channel plays a key role in allergic asthma Source: International Congress 2016 – Asthma: from basic mechanisms to novel therapeutic perspectives Year: 2016 Nicotine impairs inflammation-induced airway relaxation in a in vitro murine model of asthma Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury Year: 2013 Andrographolide restores steroid sensitivity to block LPS/IFN-γ-induced IL-27 and airway hyperresponsiveness in mice Source: International Congress 2015 – New models for treating airway diseases Year: 2015 Transient receptor potential channels in a mouse model of isocyanate-induced airway hyperresponsiveness Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation Year: 2014 Involvement of the BK channels/G proteins processes in the synergistic effects between anticholinergic agents and beta2-adrenoceptor agonists in airway smooth muscle Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management Year: 2013 Role of TRPV1 and TRPV2 gene polymorphisms in the development of airway hyperresponsiveness to osmotic stimuli in patients with asthma Source: International Congress 2016 – Role of genetics and exposures in COPD and asthma Year: 2016 Beneficial effects of menthol are mediated via a TRPM8-independent mechanism Source: International Congress 2015 – Novel targets and strategies for the treatment of cough, asthma, rhinosinusitis and COPD Year: 2015 LATE-BREAKING ABSTRACT: The PDE4 inhibitor CHF-6001 and LAMAs cooperatively inhibit bronchoconstriction-induced remodeling in lung slices Source: International Congress 2016 – Late-breaking topics in airways disease Year: 2016 The muscarinic M3 receptor regulates allergen-induced airway remodeling in mice Source: Annual Congress 2013 –Asthma drugs: new findings Year: 2013 Ciclesonide and tiotropium synergistically inhibit airway eosinophilia in a guinea pig model of chronic asthma Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management Year: 2013 Novel oral voltage-gated sodium channel (Nav) inhibitors inhibit capsaicin induced cough in conscious guinea pigs Source: International Congress 2015 – New models for treating airway diseases Year: 2015 Expression of CysLT2 receptors in asthmatic lung, and the roles in bronchoconstriction Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 Prostacyclin IP receptor activation blocks hyperosmolar-induced bronchoconstriction in isolated human small airways Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action Year: 2016 Effects of the new ultra-long-acting β2-AR agonist indacaterol in chronic treatment alone or in combination with the β1-AR blocker metoprolol on cardiac remodelling Source: International Congress 2015 – Safety of and interactions between current treatments for asthma and COPD Year: 2015